HealthObesity Drug Ozempic's Pricetag Under Fire as Study Exposes Manufacturing Costs Recent research has raised concerns over the high prices of Novo Nordisk's obesity drug Ozempic despite low manufacturing costs.by QuincyJon
TechNissan Aims High Amid 'Extreme Market Volatility': Plans 30 New Models, 30% EV Cost Cutby Quincy Jon
TechApple Vision Pro Mainland China Debut Confirmed as Tim Cook Reveals Launch Plans, Potential Dateby Quincy Jon
TechUK Competition Watchdog Targets $19B Vodafone-Three Merger Impact on Prices and Infrastructureby Quincy Jon
TechSiemens Bolsters Portfolio: Set to Acquire ebm-papst's Industrial Drive Technology Armby Quincy Jon